Chemical Parks in Europe
Facts and figures provided by ECSPP

ECSPP promotes new investments in Europe's integrated, innovative and competitive chemical industrial clusters and complexes.

About us
Member sign in
Not a member?

€200Mln Pharma and CDMO investment (2015) by Sanofi for Insulin at Industriepark Höchst in Germany

About this project

Pharma and CDMO investment of € 200 mln by Sanofi at Industriepark Höchst in Germany, Europe, targeting the production of Insulin.

Investment details

Park

Industriepark Höchst

Frankfurt-Höchst , Hessen, Germany
Total area: 460.0ha
Free: 50.0ha
Amount € 200 mln
Categories
Pharma
CDMO
Investors
Target substances
Insulin Product
Detailed data on 1100+ projects in Europe
PIPS Chemical Insights

Related news